International Drug Policy Consortium

Tweet this page
Registration as it was on 10 Oct 2022
How to read and use this data card.
Download this datacard


Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Apr 2021 - Mar 2022

Lobbyists (Full time equivalent)

7.25 Fte (8)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    International Drug Policy Consortium   (IDPC)

    EU Transparency Register

    75318797051-52 First registered on 01 Nov 2011

    Goals / Remit

    IDPC is a a global network of NGOs that come together to amplify and strengthen a diverse global movement to repair the harms caused by punitive drug policies, and promote just responses. Our advocacy positions are based on five core policy principles - drug policies should:
    - be developed through an objective assessment of priorities and evidence
    - comply with human rights principles, laws and standards
    - focus on reducing the harmful consequences, rather than the scale, of drug use and markets
    - promote social justice and the inclusion of marginalised groups
    - meaningfully involve civil society and affected populations.

    IDPC produces briefing papers, disseminates key resources on drug policy, builds the advocacy capacity of our members and partners, and offers expert advice to policy makers and officials around the world. Our global membership has expertise and experience on the wide spectrum of drug policy issues.

    Main EU files targeted

    IDPC is part of the EU Civil Society Forum on Drugs (CSFD). As such, we engage directly in activities aimed at advising and providing recommendations to EU institutions around drug policy issues. IDPC's Research and Advocacy Officer is a member of the Core Group of the CSFD.

    Individually, IDPC also collaborates with partners to organise seminars and discussions, as well as produce briefing papers and position papers on European drug policies. IDPC holds regular meetings with EU institutions, including the EMCDDA, Members of European Parliament, the HDG, the European Council, the European Commission (DG Home) and the EEAS.


    Head Office
    61 Mansell Street
    London E1 8AN
    EU Office
    61 Mansell Street
    London E1 8AN


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    IDPC staff includes seven full time staff members and one part time staff member. We also hire consultants around the world who work on thematic or regional issues related to drug policy. Three members of our staff are regularly in touch with EU institutions. For more information on the IDPC team, please visit:

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Non-governmental organisations, platforms and networks and similar

  • Networking


    IDPC is a member of the European Civil Society Forum on Drugs, of the Vienna NGO Committee on Drugs, and of the New York NGO Committee on Drugs, as well as CoNGO. IDPC also has ECOSOC Consultative Status.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Apr 2021 - Mar 2022

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year


    Major funding types in closed year

    Grants, EU funding

    Major contributions in closed year

    Contribution GIZ 105,064€
    Contribution Open Society Foundations 155,000€
    Contribution Robert Carr Fund 1,327,000€
    Contribution VOICE 48,000€
    Grant European Commission (via UNAD) 6,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    Commission expert group - Civil Society Forum on Drugs#E02681# #Member #C#Civil society#Sub-group on Relations with International Institutions

    Groups (European Parliament)


    Other activities

    For 3 years (2010-2014), under grants from the European Commission Drug Prevention and Information Programme, IDPC conducted a number of activities across Europe, in collaboration with key NGO partners.

    In 2010-2011, IDPC supported the creation of a dynamic network of NGOs from South East Europe to promote exchange of information and experience among professionals in the field of drug policy in the region. We also produced a number of publications focused on South East Europe and Western European countries.

    Between 2012 and 2014, IDPC was involved in a project funded by the European Commission in collaboration with the Transnational Institute and other European NGOs. This project aimed to promote exchange of experience through informal drug policy dialogues, expert seminars and the drafting of expert publications on issues related to the European Union and European countries.

  • Meetings


    None declared

Download this datacard